Ateronon Explained

Ateronon is a nutraceutical composed of lactolycopene, a combination of lycopene from tomato oleoresin and a whey protein matrix which increases the absorption / bioavailability of lycopene.[1] [2]

A report containing data on Ateronon was presented at the British Cardiovascular Society Conference in June 2014.[3]

Studies

LactoLycopene has been used in numerous studies focused on lycopene bioavailability. A University of Cambridge study shows that lycopene levels in the blood rose between 60% and 100% within two months for people taking LactoLycopene, while another study at Boston's Brigham & Women's Hospital, run by Harvard Medical School, found that it increased average blood levels of lycopene at both six and 12 months.[4]

It has also been used to investigate the effects of lycopene on heart function [5] [6] and male fertility.

A study at the Cleveland Clinic found that lycopene can boost sperm quality by up to 70 per cent,[7] while a team of researchers at the University of Sheffield found that LactoLycopene supplementation significantly increases the percentage of fast progressive sperm as well as normal and healthy sperm forms.[8]

History

Ateronon was developed by Cambridge Theranostics Ltd, UK, and launched in 2009.[9] The patent is currently held by its successor company, FutureYou Cambridge.

Notes and References

  1. Richelle M, Bortlik K, Liardet S, etal . A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste . J. Nutr. . 132 . 3 . 404–8 . March 2002 . 11880563 . Clinical trial. 10.1093/jn/132.3.404 . free .
  2. Blume-Peytavi U, Rolland A, Darvin ME, etal . Cutaneous lycopene and beta-carotene levels measured by resonance Raman spectroscopy: high reliability and sensitivity to oral lactolycopene deprivation and supplementation . Eur J Pharm Biopharm . 73 . 1 . 187–94 . September 2009 . 19442725 . 10.1016/j.ejpb.2009.04.017 . Clinical trial.
  3. Web site: Ateronon briefing sponsored symposium at the British Cardiovascular Society Annual Conference. 2014-06-03. June 2014.
  4. Karppi J, Laukkanen JA, Sivenius J, Ronkainen K, Kurl S . 29290243 . Serum lycopene decreases the risk of stroke in men. . Neurology. 73 . 1 . 187–94 . September 2009 . 23045517. 10.1212/WNL.0b013e31826e26a6 . Clinical trial.
  5. Gajendragadkar PR, Hubsch A, Mäki-Petäjä KM, Serg M, Wilkinson IB, Cheriyan J . Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial . PLOS ONE . 9 . 6 . e99070 . June 2014 . 10.1371/journal.pone.0099070 . 24911964 . 4049604 . Clinical trial. 2014PLoSO...999070G . free .
  6. Karppi J, Laukkanen JA, Sivenius J, Ronkainen K, Kurl S . 29290243 . Serum lycopene decreases the risk of stroke in men . Neurology . 79 . 15 . 1540–1547 . October 2012 . 10.1212/WNL.0b013e31826e26a6 . 23045517 . Clinical trial.
  7. Durairajanayagam D, Agarwal A, Ong C, Prashast P . Lycopene and male infertility . Asian Journal of Andrology. 16 . 3 . 420–425 . March 2014 . 24675655 . 4023371 . 10.4103/1008-682X.126384 . Clinical trial . free .
  8. Williams EA, Parker M, Robinson A et al . A randomized placebo-controlled trial to investigate the effect of lactolycopene on semen quality in healthy males . European Journal of Nutrition. September 2019 . 59 . 2 . 825–833 . 10.1007/s00394-019-02091-5 . 31591650 . 7058571 . Clinical trial. free .
  9. News: Tomato pill 'beats heart disease'. 2017-02-12. BBC News. 1 June 2009.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ateronon".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.